Gainers
- Rani Therapeutics Hldgs RANI stock rose 7.36% to $35.0 during Wednesday's after-market session. The company's market cap stands at $690.0 million. As per the news, the Q3 earnings report came out 2 days ago.
- Acorda Therapeutics ACOR stock increased by 4.55% to $3.67. The company's market cap stands at $40.8 million.
- ENDRA Life Sciences NDRA shares moved upwards by 4.27% to $1.22. The company's market cap stands at $51.0 million. The company's, Q3 earnings came out 2 days ago.
- 180 Life Sciences ATNF shares rose 3.83% to $3.79. The market value of their outstanding shares is at $127.2 million. As per the news, the Q3 earnings report came out 2 days ago.
- PhaseBio Pharmaceuticals PHAS shares rose 3.59% to $2.88. This security traded at a volume of 71.6K shares come close, making up 14.03% of its average volume over the last 100 days. The market value of their outstanding shares is at $138.4 million.
- Geron GERN stock increased by 3.52% to $1.47. Geron's trading volume hit 311.3K shares by close, accounting for 17.31% of its average volume over the last 100 days. The market value of their outstanding shares is at $473.2 million.
Losers
- Compass Therapeutics CMPX stock fell 5.2% to $3.65 during Wednesday's after-market session. The market value of their outstanding shares is at $355.5 million.
- Odonate Therapeutics ODT stock declined by 5.16% to $2.21. This security traded at a volume of 2.2 million shares come close, making up 1064.34% of its average volume over the last 100 days. The company's market cap stands at $85.0 million.
- Rockwell Medical RMTI stock fell 4.84% to $0.52. The company's market cap stands at $48.8 million. The company's, Q3 earnings came out 2 days ago.
- Progenity PROG shares fell 4.1% to $4.68. This security traded at a volume of 1.5 million shares come close, making up 2.3% of its average volume over the last 100 days. The market value of their outstanding shares is at $766.3 million.
- AnPac Bio-Medical Science ANPC stock fell 3.94% to $1.71. The market value of their outstanding shares is at $24.1 million.
- Akari Therapeutics AKTX stock decreased by 3.66% to $1.58. The market value of their outstanding shares is at $75.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in